Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is currently the leading cause of cancer-related death worldwide, and the incidence of brain metastases (BM) in NSCLC patients is continuously increasing. The recent improvements of systemic treatment in NSCLC necessitate continuous updates on prognostic subgroups...

Descripción completa

Detalles Bibliográficos
Autores principales: Piffko, Andras, Asey, Benedikt, Dührsen, Lasse, Ristow, Inka, Salamon, Johannes, Wikman, Harriet, Maire, Cecile L., Lamszus, Katrin, Westphal, Manfred, Sauvigny, Thomas, Mohme, Malte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631813/
https://www.ncbi.nlm.nih.gov/pubmed/36338751
http://dx.doi.org/10.3389/fonc.2022.951805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631813/
https://www.ncbi.nlm.nih.gov/pubmed/36338751
http://dx.doi.org/10.3389/fonc.2022.951805

Ejemplares similares